Department of Radiation Oncology, Winship Cancer Institute, Emory University, Atlanta, GA.
Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX.
J Clin Oncol. 2023 Aug 1;41(22):3826-3838. doi: 10.1200/JCO.22.02320. Epub 2023 Jun 12.
Radiation-associated cardiac disease is a major cause of morbidity/mortality among childhood cancer survivors. Radiation dose-response relationships for cardiac substructures and cardiac diseases remain unestablished.
Using the 25,481 5-year survivors of childhood cancer treated from 1970 to 1999 in the Childhood Cancer Survivor Study, we evaluated coronary artery disease (CAD), heart failure (HF), valvular disease (VD), and arrhythmia. We reconstructed radiation doses for each survivor to the coronary arteries, chambers, valves, and whole heart. Excess relative rate (ERR) models and piecewise exponential models evaluated dose-response relationships.
The cumulative incidence 35 years from diagnosis was 3.9% (95% CI, 3.4 to 4.3) for CAD, 3.8% (95% CI, 3.4 to 4.2) for HF, 1.2% (95% CI, 1.0 to 1.5) for VD, and 1.4% (95% CI, 1.1 to 1.6) for arrhythmia. A total of 12,288 survivors (48.2%) were exposed to radiotherapy. Quadratic ERR models improved fit compared with linear ERR models for the dose-response relationship between mean whole heart and CAD, HF, and arrhythmia, suggesting a potential threshold dose; however, such departure from linearity was not observed for most cardiac substructure end point dose-response relationships. Mean doses of 5-9.9 Gy to the whole heart did not increase the risk of any cardiac diseases. Mean doses of 5-9.9 Gy to the right coronary artery (rate ratio [RR], 2.6 [95% CI, 1.6 to 4.1]) and left ventricle (RR, 2.2 [95% CI, 1.3 to 3.7]) increased risk of CAD, and to the tricuspid valve (RR, 5.5 [95% CI, 2.0 to 15.1]) and right ventricle (RR, 8.4 [95% CI, 3.7 to 19.0]) increased risk of VD.
Among children with cancer, there may be no threshold dose below which radiation to the cardiac substructures does not increase the risk of cardiac diseases. This emphasizes their importance in modern treatment planning.
放射性心脏疾病是儿童癌症幸存者发病率和死亡率的主要原因。心脏亚结构和心脏疾病的放射剂量反应关系尚未确定。
利用 1970 年至 1999 年期间治疗的 25481 名 5 年儿童癌症幸存者,我们评估了冠心病(CAD)、心力衰竭(HF)、瓣膜疾病(VD)和心律失常。我们为每位幸存者重建了冠状动脉、心室、瓣膜和整个心脏的放射剂量。超额相对危险度(ERR)模型和分段指数模型评估了剂量反应关系。
从诊断起 35 年的累积发病率为 CAD 3.9%(95%CI,3.4 至 4.3)、HF 3.8%(95%CI,3.4 至 4.2)、VD 1.2%(95%CI,1.0 至 1.5)和心律失常 1.4%(95%CI,1.1 至 1.6)。共有 12288 名幸存者(48.2%)接受了放射治疗。与线性 ERR 模型相比,平均全心脏和 CAD、HF 和心律失常的剂量反应关系的二次 ERR 模型改善了拟合度,表明存在潜在的阈值剂量;然而,大多数心脏亚结构终点剂量反应关系并未观察到这种偏离线性。全心脏 5-9.9Gy 的平均剂量不会增加任何心脏病的风险。全心脏 5-9.9Gy 的平均剂量增加了 CAD 的风险,右侧冠状动脉(比率比 [RR],2.6[95%CI,1.6 至 4.1])和左心室(RR,2.2[95%CI,1.3 至 3.7]),增加了三尖瓣(RR,5.5[95%CI,2.0 至 15.1])和右心室(RR,8.4[95%CI,3.7 至 19.0])的 VD 风险。
在儿童癌症患者中,可能不存在低于该剂量的亚结构放射剂量不会增加心脏病风险的阈值剂量。这强调了它们在现代治疗计划中的重要性。